DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
NORLEUCINE
1
Small molecule
Investigational
Unknown
Unknown
Hot Flashes; Malaria
Unknown
NORLEUCINE
×
Maximum Phase:
1
First Approval:
None
UNII:
832C8OV84S
Molecule Type:
Small molecule
Molecular Formula:
C6H13NO2
Molecular Weight:
131.18
AlogP:
0.59
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
4.0
Source:
INTOPLICINE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
INTOPLICINE
×
Maximum Phase:
1
First Approval:
None
UNII:
FB2CIN6HMI
Molecule Type:
Small molecule
Molecular Formula:
C21H24N4O
Molecular Weight:
348.45
AlogP:
4.25
PSA:
64.18
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TINOSTAMUSTINE
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Melanoma; Multiple Myeloma
Unknown
TINOSTAMUSTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
29DKI2H2NY
Molecule Type:
Small molecule
Molecular Formula:
C19H28Cl2N4O2
Molecular Weight:
415.37
AlogP:
3.86
PSA:
70.39
HBD:
2.0
HBA:
#RotB:
12.0
Source:
CRS-3123
1
Small molecule
Investigational
Unknown
Unknown
Clostridium Infections; Colitis; Infections
Methionine--tRNA ligase inhibitor
CRS-3123
×
Maximum Phase:
1
First Approval:
None
UNII:
2P987FW4E8
Molecule Type:
Small molecule
Molecular Formula:
C19H19Br2N3O2S
Molecular Weight:
513.26
AlogP:
5.03
PSA:
66.15
HBD:
3.0
HBA:
#RotB:
6.0
Source:
MK-1496
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
MK-1496
×
Maximum Phase:
1
First Approval:
None
UNII:
CS17H9370C
Molecule Type:
Small molecule
Molecular Formula:
C14H24N2O
Molecular Weight:
236.36
AlogP:
2.13
PSA:
58.28
HBD:
3.0
HBA:
#RotB:
4.0
Source:
RG7342
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Metabotropic glutamate receptor 5 modulator
RG7342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIP-1095 I-123
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MIP-1095 I-123
×
Maximum Phase:
1
First Approval:
None
UNII:
HD4940602J
Molecule Type:
Small molecule
Molecular Formula:
C19H25IN4O8
Molecular Weight:
560.33
AlogP:
1.65
PSA:
194.16
HBD:
7.0
HBA:
#RotB:
13.0
Source:
MSC-2363318A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MSC-2363318A
×
Maximum Phase:
1
First Approval:
None
UNII:
0DXG50I4WD
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOSULPIRIDE
1
Small molecule
Investigational
Unknown
Unknown
Dyspepsia; Psychomotor Agitation; Psychotic Disorders
Dopamine D2 receptor antagonist
LEVOSULPIRIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
JTG7R315LK
Molecule Type:
Small molecule
Molecular Formula:
C15H23N3O4S
Molecular Weight:
341.43
AlogP:
0.56
PSA:
101.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
YTTRIUM Y-90
1
Small molecule
Investigational
Unknown
Unknown
Neoplasm Metastasis; Neoplasms; Bile Duct Neoplasms; Cholangiocarcinoma
Unknown
YTTRIUM Y-90
×
Maximum Phase:
1
First Approval:
None
UNII:
1K8M7UR6O1
Molecule Type:
Small molecule
Molecular Formula:
Y
Molecular Weight:
89.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
IOFOLASTAT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IOFOLASTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
9T6EBU5ER1
Molecule Type:
Small molecule
Molecular Formula:
C19H26IN3O7
Molecular Weight:
535.34
AlogP:
1.62
PSA:
165.06
HBD:
6.0
HBA:
#RotB:
14.0
Source:
RGI-7000
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis B, Chronic; Hepatitis C, Chronic; Lung Neoplasms; Multiple Myeloma
Unknown
RGI-7000
×
Maximum Phase:
1
First Approval:
None
UNII:
WX671898JF
Molecule Type:
Small molecule
Molecular Formula:
C50H99NO9
Molecular Weight:
858.34
AlogP:
10.48
PSA:
168.94
HBD:
7.0
HBA:
#RotB:
44.0
Source:
BMS-188797
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-188797
×
Maximum Phase:
1
First Approval:
None
UNII:
0HG7S0S581
Molecule Type:
Small molecule
Molecular Formula:
C47H51NO15
Molecular Weight:
869.92
AlogP:
3.96
PSA:
230.52
HBD:
4.0
HBA:
#RotB:
10.0
Source:
PLX8394
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PLX8394
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CAFUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
CAFUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HKI-357
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HKI-357
×
Maximum Phase:
1
First Approval:
None
UNII:
39R3638KZ6
Molecule Type:
Small molecule
Molecular Formula:
C31H29ClFN5O3
Molecular Weight:
574.06
AlogP:
6.68
PSA:
99.51
HBD:
2.0
HBA:
#RotB:
11.0
Source:
1.ALPHA.-HYDROXYVITAMIN D5
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
1.ALPHA.-HYDROXYVITAMIN D5
×
Maximum Phase:
1
First Approval:
None
UNII:
XY02042OD4
Molecule Type:
Small molecule
Molecular Formula:
C29H48O2
Molecular Weight:
428.7
AlogP:
7.23
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
7.0
Source:
H-100
1
Small molecule
Investigational
Unknown
Unknown
Penile Induration
Unknown
H-100
×
Maximum Phase:
1
First Approval:
None
UNII:
5RQ73K2EC8
Molecule Type:
Small molecule
Molecular Formula:
C11H11N3O3
Molecular Weight:
233.23
AlogP:
0.44
PSA:
102.22
HBD:
3.0
HBA:
#RotB:
5.0
Source:
SJ-733
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
SJ-733
×
Maximum Phase:
1
First Approval:
None
UNII:
VT3A7NA96K
Molecule Type:
Small molecule
Molecular Formula:
C24H16F4N4O2
Molecular Weight:
468.41
AlogP:
4.57
PSA:
86.09
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IMD-2560
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-2560
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PPL-100
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
PPL-100
×
Maximum Phase:
1
First Approval:
None
UNII:
JRI5GOF0K0
Molecule Type:
Small molecule
Molecular Formula:
C33H44N4O6S
Molecular Weight:
624.8
AlogP:
4.12
PSA:
151.06
HBD:
4.0
HBA:
#RotB:
16.0
Source:
LB-102
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
LB-102
×
Maximum Phase:
1
First Approval:
None
UNII:
N81WKW91XF
Molecule Type:
Small molecule
Molecular Formula:
C18H29N3O4S
Molecular Weight:
383.51
AlogP:
1.74
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SULCARDINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SULCARDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
4Q5HLV8HG1
Molecule Type:
Small molecule
Molecular Formula:
C24H33N3O4S
Molecular Weight:
459.61
AlogP:
3.07
PSA:
82.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
AZD2461
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
AZD2461
×
Maximum Phase:
1
First Approval:
None
UNII:
3K288XF5XJ
Molecule Type:
Small molecule
Molecular Formula:
C22H22FN3O3
Molecular Weight:
395.43
AlogP:
2.9
PSA:
75.29
HBD:
1.0
HBA:
#RotB:
4.0
Source:
HYPERICIN
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Lymphoma, T-Cell; Photochemotherapy; Psoriasis; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides
Unknown
HYPERICIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7V2F1075HD
Molecule Type:
Small molecule
Molecular Formula:
C30H16O8
Molecular Weight:
504.45
AlogP:
5.08
PSA:
155.52
HBD:
6.0
HBA:
#RotB:
0.0
Source:
HYODEOXYCHOLIC_ACID
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
LXR-alpha agonist
HYODEOXYCHOLIC_ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
7A33Y6EHYK
Molecule Type:
Small molecule
Molecular Formula:
C24H40O4
Molecular Weight:
392.58
AlogP:
4.48
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
4.0
Source:
PYRUVATE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis; Severe Acute Respiratory Syndrome
Unknown
PYRUVATE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
POD38AIF08
Molecule Type:
Small molecule
Molecular Formula:
C3H3NaO3
Molecular Weight:
110.04
AlogP:
-0.34
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
1.0
Source:
VERDINEXOR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VERDINEXOR
×
Maximum Phase:
1
First Approval:
None
UNII:
85Q03215IW
Molecule Type:
Small molecule
Molecular Formula:
C18H12F6N6O
Molecular Weight:
442.32
AlogP:
3.99
PSA:
84.73
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TAK-593
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Platelet-derived growth factor receptor inhibitor
TAK-593
×
Maximum Phase:
1
First Approval:
None
UNII:
H3I42X8XX7
Molecule Type:
Small molecule
Molecular Formula:
C23H23N7O3
Molecular Weight:
445.48
AlogP:
3.47
PSA:
115.44
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VINPOCETINE
1
Small molecule
Investigational
Unknown
Unknown
Epilepsy; Diabetic Nephropathies; Attention Deficit Disorder with Hyperactivity
Unknown
VINPOCETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
543512OBTC
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O2
Molecular Weight:
350.46
AlogP:
4.15
PSA:
34.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
RALANITEN ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RALANITEN ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
L10K286T2H
Molecule Type:
Small molecule
Molecular Formula:
C27H33ClO8
Molecular Weight:
521.01
AlogP:
4.44
PSA:
97.36
HBD:
0.0
HBA:
#RotB:
13.0
Source:
CYC-116
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
CYC-116
×
Maximum Phase:
1
First Approval:
None
UNII:
YAX4981K2D
Molecule Type:
Small molecule
Molecular Formula:
C18H20N6OS
Molecular Weight:
368.47
AlogP:
3.07
PSA:
89.19
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BMS-184476
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BMS-184476
×
Maximum Phase:
1
First Approval:
None
UNII:
3811W2NBZ8
Molecule Type:
Small molecule
Molecular Formula:
C49H55NO14S
Molecular Weight:
914.04
AlogP:
5.08
PSA:
210.29
HBD:
3.0
HBA:
#RotB:
13.0
Source:
PCO-371
1
Small molecule
Investigational
Unknown
Unknown
Hypoparathyroidism
Unknown
PCO-371
×
Maximum Phase:
1
First Approval:
None
UNII:
TE53TU0WSQ
Molecule Type:
Small molecule
Molecular Formula:
C29H32F3N5O6S
Molecular Weight:
635.67
AlogP:
3.32
PSA:
137.48
HBD:
2.0
HBA:
#RotB:
7.0
Source:
1
2
…
79
80
81
82
83
84
85
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA